<SEC-DOCUMENT>0001493152-25-024619.txt : 20251121
<SEC-HEADER>0001493152-25-024619.hdr.sgml : 20251121
<ACCEPTANCE-DATETIME>20251121160537
ACCESSION NUMBER:		0001493152-25-024619
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251121
DATE AS OF CHANGE:		20251121

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kindly MD, Inc.
		CENTRAL INDEX KEY:			0001946573
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				843829824
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-274606
		FILM NUMBER:		251507933

	BUSINESS ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
		BUSINESS PHONE:		(385) 388-8220

	MAIL ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>form424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS
    SUPPLEMENT</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
    Prospectus dated May 6, 2025</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Pursuant to 424(b)(3)</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
    No. 333-274606</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KINDLY
MD, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="form424b3_001.jpg" ALT="" STYLE="height: 70px; width: 320px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,059,811
Shares of Common Stock Issuable Upon Exercise of Previously Issued Warrants </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>82,310
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus supplement updates and supplements the information contained in the prospectus dated May 6, 2025 (as may be supplemented or
amended from time to time, the &ldquo;Prospectus&rdquo;), which forms part of our registration statement on Form S-1 (File No. 333-274606),
as amended, with the information contained in our Quarterly Report on Form 10-Q which was filed with the Securities and Exchange Commission
on November 19, 2025 (the &ldquo;Quarterly Report&rdquo;). Accordingly, we have attached the Quarterly Report to this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Prospectus and this prospectus supplement relate to the issuance by Kindly MD, Inc., a Utah corporation, of up to 2,059,811 shares of
common stock underlying the tradeable warrants (the &ldquo;Tradeable Warrants&rdquo;), the non-tradeable warrants (the &ldquo;Non-tradeable
Warrants&rdquo;) and the representative&rsquo;s warrants (the &ldquo;Representative&rsquo;s Warrants&rdquo; and, together with the Tradeable
Warrants and the Non-tradeable Warrants, the &ldquo;Warrants&rdquo;) previously issued by us in our initial public offering that closed
on June 3, 2024. We are not selling any shares of our common stock in this offering, and, as a result, we will not receive any proceeds
from the sale of the common stock covered by this prospectus. All of the net proceeds from the sale of our common stock will go to the
holders of the Warrants. Upon exercise of the Warrants, however, we will receive proceeds from the exercise of such Warrants if exercised
for cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Prospectus and the prospectus supplement also relate to the resale from time to time by the selling stockholders named in the Prospectus
(the &ldquo;Selling Stockholders&rdquo;) of 82,310 shares of common stock. We will not receive any proceeds from the sale of shares of
common stock by the Selling Stockholders pursuant to the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus supplement in conjunction with the Prospectus. This prospectus supplement is qualified by reference to the
Prospectus except to the extent that the information in this prospectus supplement supersedes the information contained in the Prospectus.
This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with, the Prospectus. If
there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information
in this prospectus supplement. Terms used in this prospectus supplement but not defined herein shall have the meanings given to such
terms in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;NAKA&rdquo; and our Tradeable Warrants
are listed under the symbol &ldquo;NAKAW.&rdquo; The last reported sale price of our common stock on Nasdaq on November 20, 2025 was
$0.48 per share and the last reported sale price of our Tradeable Warrants on Nasdaq on November 20, 2025 was $1.49 per warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 20 of the Prospectus and in the other
documents that are incorporated by reference in the Prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued
under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the
contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The date of this prospectus supplement is November 21, 2025.</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form424b3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form424b3_001.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MTM 'P[>?\%4/"NF:]J%C=>!M:>"TNI;<7-K<P2>8$<KO"L5X.,]>]>B>!_\
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MMC&254$%LCPW]DC]F36?VJ/'M]\1OB'+<7WA<7K3W5Q<';)K=T",Q+C&(5.
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M"G@_2?BIJGQ&M=%AB\7:E:)9W%^&/S(N!D+G 8A44L!DA%';G _:Q_Y-E^*
M'_0NWO\ Z):H<N9JQOA\O6$IU)2=W9V\D?#/_!*__DL_BW_L!'_THBKR#]O;
M_D[;XC_]=;+_ --]M7KO_!*YO^+S>+/^P"?_ $HAKR/]O16;]K;XC@ D^;9=
M/^P=;5K]L\&?_(MI_P"(_9N+I3)W2-2[E551EF8X '<UX1-^W5\"[6W:9OB!
M:,H'_+*SNI&_[Y6(FOE/]JW_ (*)VGCKPKJ?@WX:V]W!9:C&UM?>(+V/R7:
MY#I;Q_>7>O!=]I + +DAAARML^KK8^A1I\SDGZ'SQ\*;A?&W[8GAJ_TD$6VH
M>.8]2@51@B#[=Y_3_KF#^%?MA7YK_P#!.C]GVXTS4)_C-XKB32=#T^UE_L=[
MTB)7#(1->$M@+$L>]58\'>QZ*"?T$TOXD>%-;M;BYTWQ+I&H6UO&\TTUK?Q2
MI&B8WNQ5CM5<C)/ R*JH[O0X\HIRIT7.IHY.Y@_';X-Z5\=/ACK/A#5W$,=Y
M&&M[P1AGM+A3NBF7G^%NHXW*67.":_$KX@> =<^%_C+5?"_B.S-EK&FR^5-'
MSM8=5D0_Q(PPRMW!'TK]]Z\%_:L_9-T#]I/PW&Y=-(\86$973=:5<X7D^1,!
MR\1//JA)9>K!BG/E=F/-,N^N0YZ?QK\3\8J*Z_XI_"3Q7\&/%4GA_P 7:1+I
M5\,F&0_-!=(/^6D,G1U/MR,X(4Y Y"NU.^J/SR=.5.7+-685Z_\ LO\ QJU;
MX*?$&[NM+<J-:T^;2I06^57?!AEQT+)(!C/9F'>O(*DM9VM;B*9#M>-@ZGT(
M.14RU1'-.";INSL]3ZE9BSL6=I&)Y9SDGW)[FDID,RW,$4R])$5_S&:<>.2<
M#W. *XC\,J*4JC3U8O?CDU].?L>_!1]:U:+QQJT)&G6C,--CD7B>;D&7_=3D
M ]VR>-HSC_ ;]E74?&]S:ZWXK@FTWPZI$B6;Y2>]YX&.J1GUX8CIC.ZON*PT
MVVTNU@M;2".WMH$6**&) JH@& J@= !QBD?L7!_"E252.88Z-DM8I]7W?EV+
M"KMXSD4ZDI:D_=0KYP_:O_8[3]J#4O#-X_BQ_#1T6*XBV)IXN?.\UHSG)D3;
MCR_?.:^CZ*:;6J,:M&%>#A45T<%\#?A6/@M\+/#_ (,74VU@:3"\7VUH!"9=
MTC/G9N;'W\=3TJ'XZ_!/0_CY\.[_ ,*:X/*CF_>VMY&@,EG<*#Y<R>XR01T9
M2RG@FO0Z*+ZW'[*')[-K38^0/V?_ -@O6/V>OB);^)]%^*4MS"R^1J&F2:*%
MBO8"<F-B)SM8'YE< E3Z@LIZS]JS]C5/VGM;\.ZB_BU_#9T>WFM_+33Q<^;Y
MC(V<F1,8V>_6OI*EJN9WN<ZP=!4G1Y?=['CNK_L\KJW[,L?P@.O-$B:+!H_]
ML?9,D^4$'F>5O[[/N[N,]:YK]DW]D5/V76\4LGBI_$O]N_9<[K 6WD^3YOI(
M^[/G>V-OO7T/12YG:QI]6I<\:EM8Z(\N_:.^"*_M!?"R^\&/K+:$+FX@G^VK
M;>>5\J0/C9N7.<8Z\9K _96_9G7]F3PCK6AIXC;Q'_:6H?;_ #WLQ;>7^Z2/
M9M#MG[F<Y'6O<**7,[6&\/3=55FO>VN?-'[2G["_A#]H35CXACOY_"OBQD6.
M;4[2$31W2J,+YT)(W,H  8,IP "2 H'C/@G_ ()1:9I^OPW/BGQ_-K>E1R;I
M-/T_3/L;S@'.UI3*Y4'H0HSCHP/-??AYH Q5<\DK7.>IE^&J3YY0U/D#X%?\
M$];?X(_&/2O'4'CB34TT]KDQZ6=+$2E98I(POF><Q^42>ASM_&NU_:T_8]T[
M]IJVT>[37&\.^(=)$D<%[]E^T12PN03%(FY2<,H*L&^7<W!S7T712YG>Y<<'
M0C2=%1]U]#X\_9B_8 'P#^(=IXTU+QO-K>HV<4T4-E96 M8")$*'S&9W:08.
M0!LPP'7'/M/[4E]X7B_9]\=?\)<ZC0GTR:.15<"1IB/W*QYX\WS=FW_:Q7JT
MH/EG'7WK\N?''_!/'XX>*/'^JSW>J:#JEKJFI3:C-JAOY8H/,E=F:4VY0LK<
MGY5# # #$<U2]YW;.2M!X.C[+#4[WN0?\$R?A')XN^+E[XWO8<Z=X7MRD#$'
M:U].A1<=CMB\TD=B\9]*_4]?NBO-_P!G_P"".C_ /X9Z;X1TEVN?(+37=](@
M1[RY<#S)6 Z9P% R=JJJY.,GTG'%3*7,[F^ POU6@H/?KZGR!^T9_P $]X_V
M@?BAJ7C%O'DFA->V\-N;-=*$X3RXPF=YF7.>O2OK/1]/_LG2[*R\SS?L\"0[
M]N-VU0,X[=*NT4.3>YTT\/3I2E."LY;A7)?%CP"/BA\-/%'A$WQTT:WITU@;
MP1>:8?,0KOV9&[&<XR*ZREJ3>24DTSY?_9:_8DC_ &:/&6KZ\OC%_$9O[#[%
M]G?3A;>7^\1]VX2MG[F,8[]:Y/X[?\$Z(_C9\6O$7C=O'\FCMJ[PO]A721,(
MO+MXH?O^<N<^5GH.N.U?9E%5S.]SA>!P\J:I./NK4_/>/_@DK#YBF3XH2,G<
M+H(4G\?M!_E7KGPL_P"";_PJ^'M];ZCJT5YXUU&%@Z#667[*K#H?(0!6'M)O
M'Z5]5T=*?/)]2:>786F^:,-2*.W2.)8U5510%"JN  .P%>&ZU^R7H7B31H['
M4[]KEX=%FTB"583&%\QY7+.JN/,C+2(QA8[6:",GH,>\45-SME3A/22"DHHI
M&AS7CSX>^&OB5H,NA>*-$LM<TJ7DVUY$'56P0&4]489.&4@CL:^,/BA_P2OT
M+49Y;SP!XJN-"R2PTO6(S=0#/14F!$B ?[7F'WHHK2+:V/.Q6&HUXMU(WL?'
M/Q>_9?\ %GP6N+B+7+W1;GRLDG3[B9\C&?XXEKS#0M%N/$.I0V5L\:33<*92
M0OXX!_E1176M8ZGYQ7A&%3EBM#]#/A7^QUXA\3Z!I4U]KNF:=;-:QYDMUDN7
M/RC^$J@_6OIKX8_LQ^"OAS/'>):2:UJL9#+?:F1(4;KE$ "J01P0-WO117*U
M;8]+AW)LO4'B?8ISON]>OF>PK&H X&?I3Z**R/T8**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!O&WIQ1M'I110 HQBBBB@!:*** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
